Santa Cruz Biotechnology offers a broad range of LRRC47 monoclonal antibodies for research focused on understanding LRRC47 protein functions. LRRC47 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRRC47, or Leucine-Rich Repeat Containing 47, is a protein that plays a critical role in the immune response, particularly in the regulation of inflammatory processes. LRRC47 is involved in the modulation of cytokine signaling and has been implicated in various diseases, making it an important target for research. Understanding LRRC47 functions can provide insights into immune system dynamics and potential therapeutic approaches. Researchers can utilize specific monoclonal antibodies to explore LRRC47 expression patterns in different tissues and cell types. Advanced research techniques supported by monoclonal antibodies enable detailed investigation of LRRC47's role in cellular pathways and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for LRRC47 research support scientists worldwide in advancing our understanding of immune system regulation and disease development.